Evidence map›Paper›PMID 29099775›Full record

ArticleInternational journal of molecular sciences2017

Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma.

Karthik V Giridhar, Carlos P Sosa, David W Hillman, Cristobal Sanhueza, Candace L Dalpiaz, Brian A Costello, Fernando J Quevedo, Henry C Pitot, Roxana S Dronca, Donna Ertz and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. The roles of NOP56 in cancer and SCA36.Pathology oncology research : POR · 2023
    Review
  2. BAG family proteins contributes to autophagy-mediated multidrug resistance of tumor.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
  3. [Effect of piRNA NU13 in regulating biological behaviors of human Wilms tumor cellsNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Prognostic Value ofInternational journal of molecular sciences · 2018
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Karthik V GiridharDepartment of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. giridhar.karthik@mayo.edu.
Carlos P SosaBiomarker Discovery, Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA. Sosa.Carlos@mayo.edu.
David W HillmanDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA. Hillman.David@mayo.edu.
Cristobal SanhuezaDepartment of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. ctsanhue@uc.cl.
Candace L DalpiazDepartment of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Dalpiaz.Candace@mayo.edu.
Brian A CostelloDepartment of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Costello.Brian@mayo.edu.
Fernando J QuevedoDepartment of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Quevedo.Fernando@mayo.edu.
Henry C PitotDepartment of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Pitot.Henry@mayo.edu.
Roxana S DroncaDepartment of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Dronca.Roxana@mayo.edu.
Donna ErtzDepartment of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Ertz.Donna@mayo.edu.
John C ChevilleDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA. Cheville.John@mayo.edu.
Krishna Vanaja DonkenaBiomarker Discovery, Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA. KDonkena@mdanderson.org.
Manish KohliDepartment of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. kohli.manish@mayo.edu.
Mayo Clinic · USMayo Clinic in Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Memorial Sloan Kettering Cancer Center (MSKCC) prognostic score is based on clinical parameters. We analyzed whole blood mRNA expression in metastatic clear cell renal cell carcinoma (mCCRCC) patients and compared it to the MSKCC score for predicting overall survival. In a discovery set of 19 patients with mRCC, we performed whole transcriptome RNA sequencing and selected eighteen candidate genes for further evaluation based on associations with overall survival and statistical significance. In an independent validation of set of 47 patients with mCCRCC, transcript expression of the 18 candidate genes were quantified using a customized NanoString probeset. Cox regression multivariate analysis confirmed that two of the candidate genes were significantly associated with overall survival. Higher expression of

Indexed as

TranscriptomeAgedBiomarkers, TumorCarcinoma, Renal CellFemaleHumansKidney NeoplasmsMaleMiddle AgedNeoplasm MetastasisPrognosisRNA, MessengerBiomarkers, TumorRNA, Messengermetastatic renal cell carcinomaprognostic biomarkerswhole blood mRNA gene expression

Identifiers

PMID29099775
PMCPMC5713295
OpenAlexW2766539790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.